Senti Biosciences, Inc.
SNTI
$2.08
-$0.02-0.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.78M | 21.67M | 33.88M | 48.61M | 10.84M |
| Total Receivables | 1.74M | 3.69M | 2.22M | 1.81M | 1.19M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.64M | 7.16M | 9.12M | 7.96M | 5.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 584.00K | 8.00K |
| Total Current Assets | 18.16M | 32.52M | 45.21M | 58.96M | 17.38M |
|
|
|||||
| Total Current Assets | 18.16M | 32.52M | 45.21M | 58.96M | 17.38M |
| Net Property, Plant & Equipment | 30.95M | 32.44M | 33.94M | 35.24M | 36.69M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.57M | 3.58M | 3.63M | 3.64M | 3.65M |
| Total Assets | 52.69M | 68.54M | 82.78M | 97.84M | 57.72M |
|
|
|||||
| Total Accounts Payable | 1.77M | 1.02M | 1.56M | 1.45M | 793.00K |
| Total Accrued Expenses | 5.04M | 3.58M | 3.42M | 6.27M | 2.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.15M | 4.98M | 4.81M | 4.75M | 4.59M |
| Total Finance Division Other Current Liabilities | 62.00K | 413.00K | 934.00K | 671.00K | 704.00K |
| Total Other Current Liabilities | 62.00K | 413.00K | 934.00K | 671.00K | 704.00K |
| Total Current Liabilities | 12.03M | 9.99M | 10.73M | 13.15M | 9.06M |
|
|
|||||
| Total Current Liabilities | 12.03M | 9.99M | 10.73M | 13.15M | 9.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 24.97M | 26.33M | 27.63M | 28.89M | 30.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.57M | 7.57M | 6.56M | 5.05M | 2.54M |
| Total Liabilities | 44.56M | 43.89M | 44.92M | 47.09M | 41.73M |
|
|
|||||
| Common Stock & APIC | 352.23M | 350.63M | 349.11M | 322.78M | 312.52M |
| Retained Earnings | -344.11M | -325.98M | -311.25M | -297.13M | -296.52M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 8.12M | 24.65M | 37.86M | 25.65M | 15.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | 25.11M | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 25.11M | -- |
|
|
|||||
| Total Common Equity | 8.12M | 24.65M | 37.86M | 25.65M | 15.99M |
| Total Preferred Equity | -- | -- | -- | 25.11M | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.12M | 24.65M | 37.86M | 50.76M | 15.99M |
|
|
|||||